Eli Lilly is the best of both worlds — a recession-resistant stock with major growth potential
The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant looks to advance drugs in its stellar pipeline. Executives detailed reasons for optimism at a major industry gathering this week. "We're looking at another…